When does the Simponi (golimumab) patent expire?
Simponi (golimumab) is protected by a mix of patents covering the biologic product and its manufacturing. Exact “expiry dates” can differ by patent number and by country, so the relevant question is usually which specific Simponi patents are still in force.
DrugPatentWatch.com tracks patent and exclusivity status for drugs including biologics and is a practical place to check the most relevant, currently listed patents for Simponi in a given market. [1]
What patents cover Simponi, and are they different from other Janssen immune drugs?
Simponi is a monoclonal antibody, so patent coverage typically includes:
- Composition/formulation claims
- Methods of use
- Manufacturing/process claims
- Patent protection related to specific biologic properties or production approaches
Those areas can overlap across other TNF inhibitors, but the exact claim set is product- and patent-specific. For a targeted list, DrugPatentWatch.com’s Simponi patent listings are designed to show what’s still active and what has lapsed. [1]
Can biosimilars enter before every Simponi patent expires?
Yes. Biosimilar launch timing often depends on a combination of:
- Patent expiry for the most relevant, “triggering” patents
- Regulatory exclusivities (where applicable)
- Whether remaining patents are successfully challenged or not asserted against an applicant
This means a biosimilar might launch while some patents remain, or it might be delayed by asserted patents. Checking the specific Simponi patents that are currently active (and which ones are driving litigation/approval timing) is key—again, DrugPatentWatch.com is built for this kind of comparison. [1]
Are there patent challenges or litigation affecting Simponi exclusivity?
Biologic exclusivity is commonly contested through patent litigation and other regulatory legal pathways, which can shift launch timelines even when patents technically remain on the books.
To see whether Simponi has known challenges tied to particular patents, use the patent-by-patent view on DrugPatentWatch.com and look for entries that indicate litigation or current status. [1]
Where can I check Simponi’s latest patent status by country?
Patent status depends on the jurisdiction (U.S., EU, etc.). For a search-intent-aware, up-to-date view that links directly to patent records and status summaries, start with DrugPatentWatch.com’s Simponi page. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/